About Yuce Biotechnology
Yuce Biotechnology is a company based in Shenzhen (China) founded in 2015 by Gao Zhibo. Yuce Biotechnology operates in a competitive market with competitors including Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
- Headquarter Shenzhen, China
- Founders Gao Zhibo
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Huada Gene
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Yuce Biotechnology
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2018 | Amount | Series B - Yuce Biotechnology | Valuation | IDG Capital |
|
| Mar, 2018 | Amount | Seed - Yuce Biotechnology | Valuation |
investors |
Investors in Yuce Biotechnology
Yuce Biotechnology has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Huada Gene, IDG Capital and Puhua Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm
|
Founded Year | Domain | Location | |
|
Health and technology startups are invested in by Puhua Capital.
|
Founded Year | Domain | Location | |
|
Genomics research and sequencing services are provided in China.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Yuce Biotechnology
Financial Statements - Yuce Biotechnology
Yuce Biotechnology Comparisons
Competitors of Yuce Biotechnology
Yuce Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic database for clinical research is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| domain | founded_year | HQ Location |
AI-based omics data analysis solutions are provided to researchers.
|
|
| domain | founded_year | HQ Location |
Developer of predictive informatics based platform for drug discovery
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| domain | founded_year | HQ Location |
Genomic data is analyzed and interpreted via web-based applications.
|
Frequently Asked Questions about Yuce Biotechnology
Yuce Biotechnology was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Yuce Biotechnology is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.
Gao Zhibo is the current CEO of Yuce Biotechnology. They have also founded this company.
Developer of gene detection services for precise immunotherapy of tumors. The company has developed an oncology drug using public data sources and mutation analysis modules. The flagship product, TrueNeon is artificial intelligence (AI) based tumor neoplastic antigen prediction technology based on tumor exon and transcriptome data. The company is using the TrueNeone platform for biomarker development, personalized cancer vaccines, and personalized cell therapy development. The company has also developed a tumor immunotherapy (IO) clinical trial navigation portal.
Yuce Biotechnology's top competitors include Helix, Benchling and BioAge Labs.
Yuce Biotechnology has 3 investors. Key investors include Huada Gene, IDG Capital, and Puhua Capital.